Getting Down to Business: Novartis Raises It's Stock Among the Business & Financial Press

Publication Date: 2007

Source: SO08 Silver Anvil Award
Product Code: 6BW-0714B03
Organization/Author/Firm: Novartis,   Ruder Finn, Inc.
Industry: Health - Medical - Pharmaceutical
Specialization(s): Investor Relations
Member price:
Non-Member price:

Secured Document - MyPRSA Login or Purchase Required Please log in to MyPRSA to View or Purchase this item.


2007 Silver Anvil Award Winner – Investor Relations – Companies with sales of more than $500 million

What a difference a year makes. Swiss pharmaceutical giant Novartis faced a challenge: despite strong performance, blockbuster medicines, and leading R&D, U.S. investors and media were overlooking the company.

Novartis challenged Ruder Finn to raise awareness and favorability among investors by increasing positive coverage in targeted business and financial outlets. RF’s campaign drove record coverage and feature stories on Novartis, and secured the company’s inclusion on ‘best-of’ lists and 'hot' stock picks. Utilizing corporate financial, product, and pipeline announcements, coupled with strategic interviews with Novartis senior executives, Ruder Finn’s campaign helped drive an 11 percent increase in Novartis’s stock.